CBD OF DENVER INC. (CBDD) REVEALS AN INDUSTRY FIRST - A LIQUEUR FLAVORED CBD EXTRACT
DENVER, Jan. 14, 2019 /PRNewswire/ -- CBD of Denver, Inc. (OTC: CBDD) is proud to announce the company has released their first CBD offering, new tinctures that are flavored to taste like your favorite liqueur. Revolutionizing the CBD industry and redefining the image of hemp products, this Organic Full Spectrum-Whole Plant CBD extract is one of the finest available in today's marketplace.
The new tincture is packaged in 30ml (1oz) bottles and with an industry first, the pipettes are marked so you can measure the same exact dose each time. The tincture works great as an additive to your morning coffee, for the quick pick me up or sublingual (under the tongue). The products are available at www.cbdhealthprofessionals.com.
CBD of Denver, Inc. explains;
"Launching this new CBD product in the rapidly growing CBD market reflects the commitment of CBD of Denver, Inc. to develop and commercialize product innovations and provide our company with a competitive advantage."
"We identified a market need and the product development team at CBD of Denver, Inc. was able to capitalize on this opportunity. We will continue to develop a robust portfolio of superior quality CBD products and innovations."
Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis strain Plasma [postbiotic] (LC-Plasma) immunization...
Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestonesNSG...
Today, The Kids Mental Health Foundation (KMHF) hosted a panel alongside the Mental Health Storytelling, which is housed at the USC Annenberg Inclusion Initiative, in New York City. The...
The Board of Juno Pharmaceuticals Corporation is excited to announce the appointment of Jean-Guy Goulet as Chief Executive Officer (CEO).
An executive with over 35 years of experience in the pharmaceutical industry, overseeing activities in Canada...
Mexico's pharmaceutical and personal care industry is undergoing significant changes with the strategic moves announced by Genomma Lab International, S.A.B. de C.V. (B.M.V.: LABB) regarding its agreement to redeem capital in Marzam.
The...
Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
The updated release reads:
ZYUS LIFE SCIENCES CORPORATION TO PRESENT AT SIDOTI VIRTUAL INVESTOR CONFERENCE MAY 8-9
NOT FOR...
